APR 03, 2016 12:16 PM PDT

Vaccine adjuvant fights infection

WRITTEN BY: Kerry Evans
Researchers from Vanderbilt University Medical Center found that a vaccine adjuvant could protect burn victims from infection.

The group found that the adjuvant monophosphoryl lipid A induces the production of granulocyte colony stimulating factor (G-CSF) to boost the production of infection-fighting neutrophils.
 
Vaccine adjuvant may protect against infection.

Lipid A is a component of lipopolysaccharide (LPS) found in Gram-negative bacteria; LPS induces a significant immune response during bacterial infection. Cells sense the presence of LPS using toll-like receptor 4, which signals the immune system that an infection is present.

Monophosphoryl lipid A (MPLA) is a component of many vaccines (anti-cancer vaccines, for example) where it is used to generate an immune response. In this application, the MPLA comes from Salmonella minnesota and has been tested in over 300,000 human subjects.

In a study published in the Journal of Leukocyte Biology, the Vanderbilt University researchers used a mouse model to test whether MPLA could help prevent infection in burn patients. They induced a burn injury in two groups of mice. One group received MPLA, and the other received only saline. The researchers then added Pseudomonas aeruginosa bacteria to the wounds and monitored how the infection spread. Mice treated with MPLA had fewer P. aeruginosa cells in their blood and lungs. They also had a higher rate of survival than saline-treated mice.

The researchers suspected that G-CSF helped stimulate neutrophils to fight infection after the mice were treated with MPLA. To test this, they blocked G-CSF production before treating the mice with MPLA. In this case, MPLA was not able to protect the mice, indicating an important role for G-CSF.

According to study author Julia Bohannon, “as a survivor of a severe burn injury myself, it is my ultimate hope that this study, and future studies that stem from these findings, will lead to effective interventions that will significantly reduce the incidence of deadly infections in burn patients, as well as other critically ill and injured patients".
 

Source: Journal of Leukocyte Biology, Lipid A in Cancer Therapy, EurekAlert, Wikipedia
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
OCT 22, 2018
Videos
OCT 22, 2018
Mad Cow Disease Identified in Scottish Cow
Stringent detection systems appear to be working, but cases still happen....
OCT 24, 2018
Drug Discovery
OCT 24, 2018
Peptide Ruptures Viral Membrane of Zika Virus
According to a recent study at Nanyang Technological University, Singapore (NTU Singapore), a newly engineered antiviral peptide will aim to attack the vir...
NOV 01, 2018
Microbiology
NOV 01, 2018
Gut Bacteria can Have an Impact on Movement
One strain of gut bacteria can change how a fruit fly moves....
NOV 05, 2018
Microbiology
NOV 05, 2018
Potential Antidote to Botulism is Found
A microbe called Clostridium botulinum and sometimes two other strains of Clostridium bacteria can make a toxic chemical called botulism....
NOV 25, 2018
Microbiology
NOV 25, 2018
Researchers Learn How Hantavirus Infects Cells
First identified in 1993, hantavirus infections can cause dangerous and potentially deadly respiratory infections....
NOV 26, 2018
Health & Medicine
NOV 26, 2018
Nontuberculous Mycobacterial Infections in Tattoos
Contracting an infection when getting a tattoo is always a major concern. Consumers should be aware of the risk of developing infections with bloodborne pa...
Loading Comments...